-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $104

Benzinga·05/06/2025 17:41:41
Listen to the news
Goldman Sachs analyst David Roman maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $120 to $104.